State governors are ready to take action on the opioid abuse epidemic. The National Governors Association released “A Compact to Fight Opioid Addiction” on July
Congress returns in September from a seven-week recess—and ready, many patients and advocates hope, to push the 21st Century Cures Act over the finish line.
July 28 marks World Hepatitis Day, part of the World Health Organization’s effort to eliminate hepatitis B and C by 2030. Each year, 10 million
Access to comprehensive information about a medication can keep physicians informed and yield better health care decisions, argues a new set of principles from the
Patients with Alzheimer’s or Parkinson’s disease may have a new source of hope: cancer drugs. A study in the Journal of Parkinson’s Disease reported promising
July 12 and 13 hearings of the FDA’s Arthritis Advisory Committee cleared the way for two new biosimilars, adalimumab and etanercerpt. The committee unanimously supported
Patient advocates have teamed up to take an important message to European physicians and policymakers: distinct names for biosimilar medications are essential. The Global Alliance